Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
03/2003
03/25/2003US6537994 Heterocyclic β3 adrenergic receptor agonists
03/25/2003US6537948 Uracil compounds and use thereof
03/25/2003US6537712 Dry development systems
03/25/2003CA2245055C Amidation of pyridines
03/25/2003CA2113908C 1-[n-(halo-3-pyridylmethyl)]-n-methylamino-1-alkylamino-2- nitroethylene derivatives for controlling fleas in domestic animals
03/20/2003WO2003022834A1 Method for synthesis of 5-(3-pyridylmethylene)-imidazolidine-2,4-dione
03/20/2003WO2003022820A1 Heteroaromatic substituted cyclopropane as corticotropin releasing hormone
03/20/2003WO2003022819A1 A process for the production of heteroaromatic nitriles improved catalyst therefor and a process for the production of said improved catalyst
03/20/2003WO2003022818A1 Method for producing 4-haloalkylnicotinic acid esters
03/20/2003WO2003022817A1 Pyridinium-betain compounds as taste enhancer
03/20/2003WO2003022801A1 Reverse hydroxamic acid derivatives
03/20/2003WO2003022285A1 Heterocyclic substituted 2- (4-phenoxy) pyridine derivatives and related compounds as sodium channel blockers for the treatment of neuronal damage and neurodegenerative conditions
03/20/2003WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
03/20/2003WO2003022276A1 Aryl substituted pyridinecarboxamides and their use as sodium channel blockers
03/20/2003WO2003022273A1 Methods of treating cytokine mediated diseases
03/20/2003WO2003022051A1 Herbicidal n-alkylsulfonamino derivatives
03/20/2003WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/20/2003WO2002067865A3 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
03/20/2003WO2002062323A3 Use of mglur5 antagonists for the treatment of pruritic conditions
03/20/2003WO2002051810A3 Integrin receptor ligands
03/20/2003WO2002048100A3 Thiosulphonic s-esters as material protective agent
03/20/2003WO2002040431B1 Compounds having fungicidal activity and processes to make and use same
03/20/2003US20030055287 Phthalic acid diamide derivatives, fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
03/20/2003US20030055286 Il-8 receptor antagonists
03/20/2003US20030055263 Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production
03/20/2003US20030055261 Compounds with growth hormone releasing properties
03/20/2003US20030055259 Method for producing 5-aryl nicotinaldehydes
03/20/2003US20030055258 New crystal modification of torasemide
03/20/2003US20030055251 Useful as neuropeptide Y receptor antagonists and as agents for therapy of cardiovascular disorders, central nervous system disorders, metabolic diseases
03/20/2003US20030055248 Il-8 receptor antagonists
03/20/2003US20030055247 Thiazolyl(pyridyl)ethyne compounds
03/20/2003US20030055246 Serine protease inhibitors
03/20/2003US20030055100 Cytotoxic compounds
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055090 For decontaminating an area exposed to a vesicant agent; for therapy of prophylaxis or inhibiting injuries induced by a vesicant agent, such as bis-2-chloroethylsulfide (HD)
03/20/2003US20030055088 Aryl substituted pyridines and the use thereof
03/20/2003US20030055086 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
03/20/2003US20030055085 For therapy of stroke, head trauma, anoxic injury, ischemic injury, hypoglycemia, epilepsy, pain, migraine headaches, Parkinson's disease, senile dementia, Huntington's Chorea, anxiety, and Alzheimer's disease
03/20/2003US20030055066 Phenoxypropanol connected with phenylpiperazine and phenoxyalkylamine terminal in its side chain
03/20/2003US20030055064 Piperazine compounds and medicinal use thereof
03/20/2003US20030055062 Heteroaryl urea neuropeptide Y Y5 receptor antagonists
03/20/2003US20030055054 CXCR3 antagonists
03/20/2003US20030055038 For therapy of central nervous system and other disorders
03/20/2003US20030055025 For therapy of bacterial infections and neoplasms,
03/20/2003US20030054298 Color photography; bleaching, fixing, development
03/20/2003US20030054198 Image display device
03/20/2003US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials
03/20/2003CA2459531A1 Heterocyclic substituted 2- (4-phenoxy) pyridine derivatives and related compounds as sodium channel blockers for the treatment of neuronal damage and neurodegenerative conditions
03/20/2003CA2459527A1 Aryl substituted pyridinecarboxamides and their use as sodium channel blockers
03/20/2003CA2458029A1 Methods of treating cytokine mediated diseases
03/20/2003CA2453259A1 Herbicidal n-alkylsulfonamino derivatives
03/19/2003EP1293997A2 Electrolytic composition, and photoelectrochemical cell
03/19/2003EP1293214A2 LTB4 antagonists and radiopharmaceuticals for imaging infection and inflammation
03/19/2003EP1292592A1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals
03/19/2003EP1292590A1 Admantane derivatives
03/19/2003EP1292586A1 Process for the preparation of pyrazolopyrimidinones
03/19/2003EP1292573A2 Substituted thioacetamides
03/19/2003EP1292564A2 Aminoalcohol derivatives
03/19/2003EP1292308A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
03/19/2003EP1080069B1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
03/19/2003EP1037637B1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
03/19/2003EP0934312B1 1,4-disubstituted piperazines
03/19/2003CN1404474A Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
03/19/2003CN1403181A Extraction and distillation process of separating 2-chloro-5-methylpyridine and 2-chloro-3-methylpridine
03/19/2003CN1103335C Processfor producing 2,5-disubstituted pyridines
03/18/2003US6534656 Short synthesis of pyridine-based pharmaceutical intermediates
03/18/2003US6534532 Carbanilides as pesticides
03/18/2003US6534529 Synergistic insecticide mixtures
03/18/2003US6534528 Treatment of a leg ulcer or a decubitus ulcer, wherein the ulcer is not infected, which comprises contacting the ulcer with a pharmaceutical which comprises a powder and at least one 1-hydroxy-2-pyridone
03/18/2003US6534513 Phenylalkanoic acid derivatives
03/18/2003US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/18/2003US6534492 Uracil substituted phenyl sulfamoyl carboxamides
03/18/2003US6534447 Herbicidal pyridine compounds
03/18/2003US6534445 Substituted pyridine herbicides
03/18/2003US6533960 Reduction of carbonyl compounds by a silane in the presence of a zinc catalyst
03/18/2003CA2217351C Carbonyl-piperazinyl and piperidinyl compounds which inhibit farnesyl protein transferase
03/13/2003WO2003022007A1 Organic light emitting devices having carrier blocking layers comprising metal complexes
03/13/2003WO2003020705A1 Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors
03/13/2003WO2003020704A1 Sulfonylamino derivatives useful as herbicides
03/13/2003WO2003020703A1 Cyclic amine compound
03/13/2003WO2003020696A1 C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments
03/13/2003WO2003020677A2 C2-substituted indane-1-ones and their derivatives, method for their production and their use as medicaments
03/13/2003WO2003020241A2 Functional powders for oral delivery
03/13/2003WO2003004472A8 Arylamines for the treatment of conditions associated with gsk-3
03/13/2003WO2002097393A3 Cleavable surfactants and methods of use thereof
03/13/2003WO2002096901A3 1,3-dihydroxybenzene derivatives and colorants containing said compounds
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/13/2003WO2002074726A3 Aniline derivatives useful as phosphodiesterase 4 inhibitors
03/13/2003WO2002053519A3 Hydrophobic polyamine analogs and methods for their use
03/13/2003WO2002050019A3 Diamines as modulators of chemokine receptor activity
03/13/2003WO2002036554A3 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
03/13/2003WO2002034708A3 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis
03/13/2003WO2002024194A3 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
03/13/2003WO2002005798A3 Pharmaceutical compositions for treating neurological disorders
03/13/2003US20030050494 Ethylene oligomerization catalyst comprising an iron complex of a 2,6-bis(1-(phenylimino)ethyl)pyridine ligand of given formula with a Lewis acid such as methylalumoxane; forms alpha-olefins of formula H-(CH2-CH2)q-CH=CH2 q=1-18
03/13/2003US20030050479 Process for the preparation of substituted oxazoles
03/13/2003US20030050329 Synergistic combination comprising roflumilast and a PDE-3 inhibitor
03/13/2003US20030050324 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
03/13/2003US20030050319 Synthesis of intermediates useful in preparing tricyclic compounds
03/13/2003US20030050317 (R)-chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
1 ... 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 ... 633